Colin Hill Insider Profile
4 Followers
Colin Hill, Director at Fulcrum Therapeutics, holds ― shares in Fulcrum Therapeutics (Ticker: FULC), holds 0.00 shares in PPD (Ticker: PPD), holds 21.65K shares in BioTelemetry (Ticker: ~BEAT).
Colin Hill's Trading History
| PPDPPD | Dec 08, 2021 | ― | Uninformative Sell | 775.67K | $0.00 | |
| ~BEATBioTelemetry | May 13, 2020 | ― | Uninformative Buy | ― | $1.56M | |
| FULCFulcrum Therapeutics | ― | Director | ― | ― |
You May Also Like
Colin Hill insider profile FAQ
What stocks does Colin Hill hold?
Colin Hill holds: FULC, ~BEAT, PPD stocks.
What is Colin Hill's role in Fulcrum Therapeutics?
Colin Hill's role in Fulcrum Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
